Title of article :
A phase III randomized trial of meloxicam started either 1 week prior to or concurrent with Iodine-125 prostate brachytherapy to reduce post-implant edema, catheterization rates and the severity of lower urinary tract symptoms
Author/Authors :
Juanita M. Crook، نويسنده , , Nikhilesh Patil، نويسنده , , David Zhou، نويسنده , , Kris Wallace، نويسنده ,
